0534505 - ÚOCHB 2021 RIV eng P - Patent Document
Baszczyňski, Ondřej - Dejmek, Milan - Hu, Y. E. - Jansa, Petr - Lansdon, E. - Mackman, R. - Šimon, Petr
Quinazoline compounds.
2019. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 19.02.2019. Patent Number: US10206926
Institutional support: RVO:61388963
Keywords : quinazoline * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=10206926B2&KC=B2&FT=D&ND=4&date=20190219&DB=&locale=en_EP
Permanent Link: http://hdl.handle.net/11104/0312841
Baszczyňski, Ondřej - Dejmek, Milan - Hu, Y. E. - Jansa, Petr - Lansdon, E. - Mackman, R. - Šimon, Petr
Quinazoline compounds.
2019. Owner: Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i. Date of the patent acceptance: 19.02.2019. Patent Number: US10206926
Institutional support: RVO:61388963
Keywords : quinazoline * reverse transcriptase * antiviral * NNRTI
OECD category: Organic chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=US&NR=10206926B2&KC=B2&FT=D&ND=4&date=20190219&DB=&locale=en_EP
Permanent Link: http://hdl.handle.net/11104/0312841